Enovis shares jump after Medicare reverses reimbursement cuts

Investing.com -- Enovis Corp shares rose approximately 11% on Monday following a decision by the Centers for Medicare & Medicaid Services to reverse previously announced reimbursement cuts for the company's non-invasive bone growth stimulators.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• OpenAI says its agents leaked some user images - Reuters
• Fed’s Hammack says public’s inflation expectations could worsen